CVA
TMO icon

Ceredex Value Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Ceredex Value Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.9M Sell
51,619
-278
-0.5% -$133K 0.73% 50
2026
Q1 		$25.5M Sell
51,897
-261
-0.5% -$142K 0.8% 34
2025
Q4 		$30.2M Buy
+52,158
New +$29.5M 0.91% 25

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ceredex Value Advisors's TMO Position: Q2 2026 in Review

Ceredex Value Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.54% in Q2 2026, selling an estimated $133K and leaving 51,619 shares worth $25.9M. The position accounts for 0.73% of the portfolio, ranked #50.

Ceredex Value Advisors first reported a position in TMO in Q4 2025 and has held it in 3 quarters since. The position peaked at $30.2M in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ceredex Value Advisors held 51,619 shares of Thermo Fisher Scientific worth $25.9M as of Q2 2026.
  • Ceredex Value Advisors sold 278 Thermo Fisher Scientific shares in Q2 2026, an estimated $133K.
  • Thermo Fisher Scientific made up 0.73% of Ceredex Value Advisors's portfolio in Q2 2026, its #50 holding.
  • Ceredex Value Advisors first reported a position in Thermo Fisher Scientific in Q4 2025 and has held it in 3 quarters since.
  • Ceredex Value Advisors's Thermo Fisher Scientific position peaked at $30.2M in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ceredex Value Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.